Cost Savings Digbi Health targets obesity and related conditions with a Precision Biology platform, delivering measurable ROI for employers through reduced healthcare utilization, including lower ER visits, fewer inpatient admissions, and decreased prescription use.

Employer & Payer Expansion With over 100 employers already offering Digbi Health and plans to integrate with insurance-covered programs and Medicare, there is a clear pathway to expand through employer benefits, step-growth with payers, and scalable telehealth delivery.

Multi-Condition Platform The single platform covers five conditions driven by biology—obesity, metabolic, digestive, autoimmune, and mental health—enabling cross-sell opportunities within large employer populations and to health plans seeking holistic, data-driven care.

Precision Biology Edge Leverage the combination of genetics, gut microbiome, continuous glucose monitoring, and AI to differentiate from traditional programs, appealing to health plans and employers seeking advanced, personalized interventions and better outcome metrics.

Clinical Adoption & Roles Recent leadership hires and clinical program launches (GLP-1 based care, GLP-Fit) signal ongoing product maturation and clinical credibility, creating talking points for medical affairs, product partnerships, and referenceable cases to accelerate adoption.